Doctor's Cameron Abrams and Irwin Chaiken are developing and testing a molecule, called a Dual Action Virolytic Entry Inhibitor--DAVEI, for short, that can put HIV out of commission by tricking the virus.
Doctor's Cameron Abrams and Irwin Chaiken are developing and testing a molecule, called a Dual Action Virolytic Entry Inhibitor--DAVEI, for short, that can put HIV out of commission by tricking the virus.
Share this Article
Recommended